{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:52:25Z","timestamp":1791402745189,"version":"4.3.3"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Asthma is a multifactorial disease driven by genetic and environmental factors that influence pathogenesis and therapeutic response. Obesity and asthma share overlapping inflammatory pathways that worsen disease severity and impair medication response. Inhaled corticosteroids (ICS) are the cornerstone of long-term persistent asthma management, yet 25\u201330% of patients exhibit poor response. Genetic variants in the\n                      <jats:italic toggle=\"yes\">T<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">GLCCI1<\/jats:italic>\n                      , and\n                      <jats:italic toggle=\"yes\">CRHR1<\/jats:italic>\n                      genes have been associated with differential ICS response; however, whether obesity modifies these pharmacogenetic relationships remains unexplored. We conducted a candidate gene analysis in the Caucasian Childhood Asthma Management Program cohort to examine whether obesity status (BMI &gt; 95\n                      <jats:sup>th<\/jats:sup>\n                      percentile; obesity:\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 24, no obesity:\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 176) modifies pharmacogenetic associations with ICS response. The primary outcome was the 2-month change in forced expiratory volume in the first second percentage predicted (FEV1PP) following ICS treatment, evaluated for single-nucleotide polymorphisms (SNPs) rs6456042, rs37972, and rs242941. The overall cohort demonstrated a 5.7% improvement in FEV1PP (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.003). The no-obesity group showed a 6.6% increase (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001), while the obesity group experienced a \u22126.2% change (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.26). Significant pharmacogenetic associations with ICS response were identified in the no-obesity group, whereas the obesity group exhibited attenuated or reversed effects for all three SNPs, most notably rs37972.These findings demonstrate for the first time that established pharmacogenetic associations with ICS response are differentially expressed by obesity status. Obesity acts as a pharmacogenetic modifier and likely represents a distinct asthma endotype with unique genetic determinants of ICS response. Endotype-based stratification incorporating obesity is a necessary step toward precision pharmacogenomics in asthma and warrants dedicated pharmacogenomic investigation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/fpc.0000000000000624","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:00:10Z","timestamp":1791399610000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacogenetics of inhaled corticosteroids in obesity-related childhood asthma"],"prefix":"10.1097","author":[{"given":"Manaswitha","family":"Khare","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of California San Diego"},{"name":"Department of Pediatrics, Rady Children\u2019s Hospital San Diego, San Diego, California"},{"name":"Divisions of Hospital Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shraddha","family":"Piparia","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California San Diego"},{"name":"Department of Pediatrics, Rady Children\u2019s Hospital San Diego, San Diego, California"},{"name":"Division of Respiratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avriti","family":"Khare","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Weiss","sequence":"additional","affiliation":[{"name":"Channing Division of Network Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelan","family":"Tantisira","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California San Diego"},{"name":"Department of Pediatrics, Rady Children\u2019s Hospital San Diego, San Diego, California"},{"name":"Division of Respiratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"R1-20261007","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1183\/13993003.00766-2016","article-title":"Childhood obesity in relation to poor asthma control and exacerbation: a meta-analysis.","volume":"48","author":"Ahmadizar","year":"2016","journal-title":"Eur Respir J"},{"key":"R2-20261007","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jaci.2010.12.010","article-title":"Decreased response to inhaled steroids in overweight and obese asthmatic children.","volume":"127","author":"Forno","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R3-20261007","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jaip.2021.10.020","article-title":"Obesity is associated with sustained symptomatology and unique inflammatory features in children with asthma.","volume":"10","author":"Fitzpatrick","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R4-20261007","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5114\/aoms\/92118","article-title":"Adipokine signatures of subcutaneous and visceral abdominal fat in normal-weight and obese women with different metabolic profiles.","volume":"17","author":"Korac","year":"2021","journal-title":"Arch Med Sci"},{"key":"R5-20261007","doi-asserted-by":"crossref","first-page":"131349","DOI":"10.1155\/2013\/131349","article-title":"Systemic inflammation and lung function impairment in morbidly obese subjects with the metabolic syndrome.","volume":"2013","author":"van Huisstede","year":"2013","journal-title":"J Obes"},{"key":"R6-20261007","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/hmg\/ddh149","article-title":"Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids.","volume":"13","author":"Tantisira","year":"2004","journal-title":"Hum Mol Genet"},{"key":"R7-20261007","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1164\/rccm.201111-2061OC","article-title":"Genome-wide association identifies the T gene as a novel asthma pharmacogenetic locus.","volume":"185","author":"Tantisira","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"R8-20261007","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJMoa0911353","article-title":"Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma.","volume":"365","author":"Tantisira","year":"2011","journal-title":"N Engl J Med"},{"key":"R9-20261007","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/resp.13052","article-title":"Mouse models of severe asthma: understanding the mechanisms of steroid resistance, tissue remodelling and disease exacerbation.","volume":"22","author":"Maltby","year":"2017","journal-title":"Respirology"},{"key":"R10-20261007","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/tpj.2012.15","article-title":"Predicting inhaled corticosteroid response in asthma with two associated SNPs.","volume":"13","author":"McGeachie","year":"2013","journal-title":"Pharmacogenomics J"},{"key":"R11-20261007","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1164\/rccm.201203-0573OC","article-title":"Obesity and asthma: an inflammatory disease of adipose tissue not the airway.","volume":"186","author":"Sideleva","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"R12-20261007","doi-asserted-by":"crossref","first-page":"e36631","DOI":"10.1371\/journal.pone.0036631","article-title":"Cluster analysis of obesity and asthma phenotypes.","volume":"7","author":"Sutherland","year":"2012","journal-title":"PLoS One"},{"key":"R13-20261007","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3389\/fimmu.2014.00440","article-title":"Induction of IL-17A precedes development of airway hyperresponsiveness during diet-induced obesity and correlates with complement factor D.","volume":"5","author":"Mathews","year":"2014","journal-title":"Front Immunol"},{"key":"R14-20261007","doi-asserted-by":"crossref","first-page":"2000612","DOI":"10.1183\/13993003.00612-2020","article-title":"Asthma medication use in obese and healthy weight asthma: systematic review\/meta-analysis.","volume":"57","author":"Thompson","year":"2021","journal-title":"Eur Respir J"},{"key":"R15-20261007","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11882-017-0719-9","article-title":"Role of obesity in asthma: mechanisms and management strategies.","volume":"17","author":"Scott","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"key":"R16-20261007","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.anai.2011.12.006","article-title":"Does body mass index influence responsiveness to inhaled corticosteroids in persistent asthma?","volume":"108","author":"Anderson","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R17-20261007","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2500\/aap.2022.43.220027","article-title":"Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma.","volume":"43","author":"Wangberg","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"R18-20261007","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mito.2013.11.002","article-title":"Association study of mitochondrial genetic polymorphisms in asthmatic children.","volume":"14","author":"Flaquer","year":"2014","journal-title":"Mitochondrion"},{"key":"R19-20261007","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/s42003-022-04070-9","article-title":"Obesity-related biomarkers underlie a shared genetic architecture between childhood body mass index and childhood asthma.","volume":"5","author":"Han","year":"2022","journal-title":"Commun Biol"},{"key":"R20-20261007","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/02770903.2022.2077218","article-title":"SNPs, adipokynes and adiposity in children with asthma.","volume":"60","author":"Machado","year":"2023","journal-title":"J Asthma"},{"key":"R21-20261007","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jaci.2019.09.035","article-title":"Shared genetic and experimental links between obesity-related traits and asthma subtypes in UK Biobank.","volume":"145","author":"Zhu","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"R22-20261007","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jaci.2005.09.016","article-title":"Genetic pleiotropy between asthma and obesity in a community-based sample of twins.","volume":"116","author":"Hallstrand","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"R23-20261007","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/jpm10030095","article-title":"CASTER: cross-sectional asthma STEroid response measurement.","volume":"10","author":"Kho","year":"2020","journal-title":"J Pers Med"},{"key":"R24-20261007","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1177\/0300060516683877","article-title":"Effects of genetic factors to inhaled corticosteroid response in children with asthma: a literature review.","volume":"45","author":"Duong-Thi-Ly","year":"2017","journal-title":"J Int Med Res"},{"key":"R25-20261007","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.3390\/ijms21082908","article-title":"Precision medicine in childhood asthma: omic studies of treatment response.","volume":"21","author":"Perez-Garcia","year":"2020","journal-title":"Int J Mol Sci"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FPC.0000000000000624","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:00:14Z","timestamp":1791399614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/FPC.0000000000000624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":25,"URL":"https:\/\/doi.org\/10.1097\/fpc.0000000000000624","relation":{},"ISSN":["1744-6872","1744-6880"],"issn-type":[{"value":"1744-6872","type":"print"},{"value":"1744-6880","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"2026-03-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}